Skip to main content
. 2018 Mar 16;8(3):e020787. doi: 10.1136/bmjopen-2017-020787

Table 5.

HRs and 95% CI for two consecutive changes of DM treatment by PCa diagnosis and PCa treatments

Multivariate analysis*
HR 95% CI
PCa diagnosis No PCa 1.00 (Ref)
PCa 1.75 1.38 to 2.22
PCa treatment No PCa 1.00 (Ref)
No ADT 1.40 1.03 to 1.92
AA 0.91 0.29 to 2.82
GnRH 3.08 2.14 to 4.44
PCa diagnosis in relation to prior change in T2DM treatment No PCa 1.00 (Ref)
PCa prior to one change 1.09 0.78 to 1.54
PCa after one change 3.59 2.61 to 4.93

*Multivariate analysis with age as time scale and adjusted for education status and initial diabetes treatment.

AA, antiandrogen; ADT, androgen deprivation therapy; GnRH, gonadotropin-releasing hormone agonist; PCa, prostate cancer; T2DM, type 2 diabetes mellitus.